Early experience on the effects of sildenafil citrate for treating erectile dysfunction after radical retropubic prostatectomy

Yong Soo Kim, Jae Seok Lee, Byung Ha Chung

Research output: Contribution to journalArticle

Abstract

Purpose: We assess the efficacy of using sildenafil for treating erectile dysfunction (ED) in Korean men after they had undergone radical retropubic prostatectomy for localized prostate cancer. Materials and methods: Between January 2002 and November 2004, 61 patients underwent RRP and post-operative sildenafil treatment for ED, and 50 patients were finally enrolled in this study. The subjects were divided into three groups according to the nerve sparing status (non-nerve sparing, unilateral nerve sparing and bilateral nerve sparing). Medication was initiated at 50mg, and if this was ineffective, then we added 50mg to the initial dosage. The patients were asked to fill out the self-administrated International Index of Erectile Function-5 (IIEF-5) for determining their response to sildenafil. Results: Of the 14 patients who underwent bilateral nerve sparing (NS) procedures, 4 (28%) had improved ability for intercourse. Of the 8 patients who underwent unilateral NS procedures, 2 (25%) had improved ability for intercourse. 1 of 28 patients who underwent non-NS procedures had a positive response. PDE5Is significantly improved the IIEF-5 (2.44 ± 1.89 vs 8.81 ± 8.24, respectively, p < 0.001). Two factors, i.e., age and preoperative sexual activity, correlated with the return of sexual function. No patient discontinued the drug because of side effects. Conclusions: For Korean men who have undergone bilateral and unilateral NS procedures, Sildenafil is effective for treating erectile dysfunction, and it may aid the recovery of erectile function after radical retropubic prostatectomy. However, non-NS procedure patients had less of a response to sildenafil. This study suggested that sildenafil is well tolerated and could be initially used for treating Korean men with erectile dysfunction after radical retropubic prostatectomy.

Original languageEnglish
Pages (from-to)392-396
Number of pages5
JournalKorean Journal of Urology
Volume47
Issue number4
DOIs
Publication statusPublished - 2006 Apr

Fingerprint

Erectile Dysfunction
Prostatectomy
Aptitude
Sildenafil Citrate
Age Factors
Recovery of Function
Drug-Related Side Effects and Adverse Reactions
Sexual Behavior
Prostatic Neoplasms

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

@article{71f6fde74c654d49b60f6b2ad4faeacb,
title = "Early experience on the effects of sildenafil citrate for treating erectile dysfunction after radical retropubic prostatectomy",
abstract = "Purpose: We assess the efficacy of using sildenafil for treating erectile dysfunction (ED) in Korean men after they had undergone radical retropubic prostatectomy for localized prostate cancer. Materials and methods: Between January 2002 and November 2004, 61 patients underwent RRP and post-operative sildenafil treatment for ED, and 50 patients were finally enrolled in this study. The subjects were divided into three groups according to the nerve sparing status (non-nerve sparing, unilateral nerve sparing and bilateral nerve sparing). Medication was initiated at 50mg, and if this was ineffective, then we added 50mg to the initial dosage. The patients were asked to fill out the self-administrated International Index of Erectile Function-5 (IIEF-5) for determining their response to sildenafil. Results: Of the 14 patients who underwent bilateral nerve sparing (NS) procedures, 4 (28{\%}) had improved ability for intercourse. Of the 8 patients who underwent unilateral NS procedures, 2 (25{\%}) had improved ability for intercourse. 1 of 28 patients who underwent non-NS procedures had a positive response. PDE5Is significantly improved the IIEF-5 (2.44 ± 1.89 vs 8.81 ± 8.24, respectively, p < 0.001). Two factors, i.e., age and preoperative sexual activity, correlated with the return of sexual function. No patient discontinued the drug because of side effects. Conclusions: For Korean men who have undergone bilateral and unilateral NS procedures, Sildenafil is effective for treating erectile dysfunction, and it may aid the recovery of erectile function after radical retropubic prostatectomy. However, non-NS procedure patients had less of a response to sildenafil. This study suggested that sildenafil is well tolerated and could be initially used for treating Korean men with erectile dysfunction after radical retropubic prostatectomy.",
author = "Kim, {Yong Soo} and Lee, {Jae Seok} and Chung, {Byung Ha}",
year = "2006",
month = "4",
doi = "10.4111/kju.2006.47.4.392",
language = "English",
volume = "47",
pages = "392--396",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "4",

}

Early experience on the effects of sildenafil citrate for treating erectile dysfunction after radical retropubic prostatectomy. / Kim, Yong Soo; Lee, Jae Seok; Chung, Byung Ha.

In: Korean Journal of Urology, Vol. 47, No. 4, 04.2006, p. 392-396.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Early experience on the effects of sildenafil citrate for treating erectile dysfunction after radical retropubic prostatectomy

AU - Kim, Yong Soo

AU - Lee, Jae Seok

AU - Chung, Byung Ha

PY - 2006/4

Y1 - 2006/4

N2 - Purpose: We assess the efficacy of using sildenafil for treating erectile dysfunction (ED) in Korean men after they had undergone radical retropubic prostatectomy for localized prostate cancer. Materials and methods: Between January 2002 and November 2004, 61 patients underwent RRP and post-operative sildenafil treatment for ED, and 50 patients were finally enrolled in this study. The subjects were divided into three groups according to the nerve sparing status (non-nerve sparing, unilateral nerve sparing and bilateral nerve sparing). Medication was initiated at 50mg, and if this was ineffective, then we added 50mg to the initial dosage. The patients were asked to fill out the self-administrated International Index of Erectile Function-5 (IIEF-5) for determining their response to sildenafil. Results: Of the 14 patients who underwent bilateral nerve sparing (NS) procedures, 4 (28%) had improved ability for intercourse. Of the 8 patients who underwent unilateral NS procedures, 2 (25%) had improved ability for intercourse. 1 of 28 patients who underwent non-NS procedures had a positive response. PDE5Is significantly improved the IIEF-5 (2.44 ± 1.89 vs 8.81 ± 8.24, respectively, p < 0.001). Two factors, i.e., age and preoperative sexual activity, correlated with the return of sexual function. No patient discontinued the drug because of side effects. Conclusions: For Korean men who have undergone bilateral and unilateral NS procedures, Sildenafil is effective for treating erectile dysfunction, and it may aid the recovery of erectile function after radical retropubic prostatectomy. However, non-NS procedure patients had less of a response to sildenafil. This study suggested that sildenafil is well tolerated and could be initially used for treating Korean men with erectile dysfunction after radical retropubic prostatectomy.

AB - Purpose: We assess the efficacy of using sildenafil for treating erectile dysfunction (ED) in Korean men after they had undergone radical retropubic prostatectomy for localized prostate cancer. Materials and methods: Between January 2002 and November 2004, 61 patients underwent RRP and post-operative sildenafil treatment for ED, and 50 patients were finally enrolled in this study. The subjects were divided into three groups according to the nerve sparing status (non-nerve sparing, unilateral nerve sparing and bilateral nerve sparing). Medication was initiated at 50mg, and if this was ineffective, then we added 50mg to the initial dosage. The patients were asked to fill out the self-administrated International Index of Erectile Function-5 (IIEF-5) for determining their response to sildenafil. Results: Of the 14 patients who underwent bilateral nerve sparing (NS) procedures, 4 (28%) had improved ability for intercourse. Of the 8 patients who underwent unilateral NS procedures, 2 (25%) had improved ability for intercourse. 1 of 28 patients who underwent non-NS procedures had a positive response. PDE5Is significantly improved the IIEF-5 (2.44 ± 1.89 vs 8.81 ± 8.24, respectively, p < 0.001). Two factors, i.e., age and preoperative sexual activity, correlated with the return of sexual function. No patient discontinued the drug because of side effects. Conclusions: For Korean men who have undergone bilateral and unilateral NS procedures, Sildenafil is effective for treating erectile dysfunction, and it may aid the recovery of erectile function after radical retropubic prostatectomy. However, non-NS procedure patients had less of a response to sildenafil. This study suggested that sildenafil is well tolerated and could be initially used for treating Korean men with erectile dysfunction after radical retropubic prostatectomy.

UR - http://www.scopus.com/inward/record.url?scp=33745593711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745593711&partnerID=8YFLogxK

U2 - 10.4111/kju.2006.47.4.392

DO - 10.4111/kju.2006.47.4.392

M3 - Article

AN - SCOPUS:33745593711

VL - 47

SP - 392

EP - 396

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 4

ER -